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Dear Editor,  
everal etiological aspects have been suggested in 
the impairment of sperm DNA part, including life-
style factors, accessory gland infections, and vari-
cocele (1-4). Sperm DNA fragmentation (SDF) has 
emerged as an biomarker for assessing male fertility 
possibilities (5) and may be informative for Intra-Uter-
ine Insemination, In Vitro Fertilization and intracyto-
plasmic sperm injection (ICSI) outcomes (6). Spermato-
zoa recoup from the testis of patient with abnormal 
ejaculated sperm DNA integrity are believed to have su-
perior DNA character (5). In a study presented by Zini 
et al,  among strategies proposed to get better SDF in 
couples undergoing ICSI, applying Testicular Sperm Ex-
traction (TESE) in favor over ejaculated sperm has 
gained increased attention owing to reports of better 
ICSI outcomes (7). 
After institutional review board approval was obtained, 
couples were subjected to history of idiopathic oligozo-
ospermia (<15 million/mL), sperm morphology >4%, 
high SDF level in TUNEL test (>30%) in two semen anal-
ysis, and one or more unsuccessful ejaculated sperm 
ICSI rounds, candidate for TESE- ICSI. All interventions 
were done under local anesthesia on an outpatient set 
up. Successful retrieval was described as the existence 
of a sufficient amount of sperm for injections. Injections 
were done with fresh specimens. Managed ovarian stim-
ulation was performed with recombinant Follicle Stim-
ulating Hormone, starting on 2nd day after beginning of 
menstrual cycle, with doses ranging from 150 to 300 
IU/day as stated by the case ovarian reserve. Recombi-
nant Human Chorionic Gonadotropin (rec-hCG 250 mg; 
Ovidrel or Pregnyl 10000 IU; Merck Serono) was deliv-
ered subcutaneous for final oocyte maturation when at 
least two follicles gained the mean diameter of 17 mm. 
36 hours after rec-hCG injection all cases were subjected 
to transvaginal ultrasound-guided oocyte pick-up. The 
fertilized oocytes were cultured, and embryo quality 
was evaluated. Abdominal ultrasound-guided embryo 
transferred (on 3rd day) after oocyte pick-up was done, 
and all cases started luteal phase assist by vaginal Pro-
gesterone administration (200 or 400 µg/ daily; Merck 
Serono).  
Due to the conception and pregnancy failure in all of the 
first 18 couples and according to the Ethics Committee 
protocol, the investigation did not continue. Patient and 
clinical characteristics are presented in Table 1. 
According to the report of previous investigations, tes-
ticular sperm appears favorable for ICSI in terms of 
lower DNA destruction, especially for couples with re-
peated Assisted Reproductive Technology failures (5, 8, 
9). However, this potential benefit could be offset by the 
higher aneuploidy rates in testicular spermatozoa (10). 
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Clinicians should balance these risks; like as intratestic-
ular hemorrhage and reduction in testosterone produc-
tion prior to the recommendation of TESE-ICSI on the 
result of a semen analysis or sperm DNA test (7). Ac-
cording to our result and Meta analyses conducted in 
this issue, it is proposed to perform TESE-ICSI in se-
lected normospermia cases. 
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Table 1: Demographic and clinical characteristics of the 
couples with TESE-ICSI 
Variable Mean ± SD 
Male age, year 37.8  ±   5.01 
Female age, year 35.62  ±   5.38 
Infertility duration, year 7.22 ±  4.58 
BMI¶ of women 25.9 ±  3.56 
Basal FSH levels, IU/L 6.59 ±  3.27 
AMHß 1.94 ± 1.03 
SDF 37.53 ±  4.09 
Oocytes Retrieved, number 6.1 ± 3.3 
Oocytes Metaphase II, number 4.37 ± 2.9 
Embryos, number 1.68 ± 2.24 
High quality Embryos on day 3 (%) 23.2 ± 18.01 
Implantation, number 1.02 ± 2.79 
 
 
